Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9531376 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Docetaxel, Cisplatin, 5-FU and Cetuximab

Indicates status has not been verified in more than two years